West Pharmaceutical Services, Inc.

NYSE:WST

Sector

🏥 Health Care

Industries

💊 Drugstores & Retail Pharmacies

🔬 Chemicals & Advanced Materials

🔬 Clinical Trials

🩺 Medical Instruments

💊 Pharmaceuticals

Location

United States

Market Cap

USD 15.51 B

Share Price

USD 215.82

Avg Daily Volume

864,763

Change (1 day)

-0.98%

Change (1 year)

-34.33%

Change (YTD)

-34.11%

West Pharmaceutical Services, Inc. Share Price Year-To-Date (YTD) return on June 20, 2025: -34.11%

West Pharmaceutical Services, Inc. Share Price Year-To-Date (YTD) return is -34.11% on June 20, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.

West Pharmaceutical Services, Inc. 52-week low Share Price is USD 347.87 on June 20, 2025, which is 61.19% above the current Share Price.
West Pharmaceutical Services, Inc. 52-week low Share Price is USD 190.39 on June 20, 2025, which is -11.78% below the current Share Price.
West Pharmaceutical Services, Inc. average Share Price for the last 52 weeks is USD 280.52.

Daily

From:

To:

Zoom:

Key data

Date	Share Price Year-To-Date (YTD) return	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)

NYSE: WST

West Pharmaceutical Services, Inc.

CEO	Mr. Eric M. Green
IPO Date	March 17, 1980
Location	United States
Headquarters	530 Herman O. West Drive
Employees	10,600
Sector	🏥 Health Care
Industries Drugstores & Retail Pharmacies 🔬 Chemicals & Advanced Materials 🔬 Clinical Trials 🩺 Medical Instruments 💊 Pharmaceuticals

Description

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.